BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

789 related articles for article (PubMed ID: 24269858)

  • 1. Nerve injury and recovery after lateral lumbar interbody fusion with and without bone morphogenetic protein-2 augmentation: a cohort-controlled study.
    Lykissas MG; Aichmair A; Sama AA; Hughes AP; Lebl DR; Cammisa FP; Girardi FP
    Spine J; 2014 Feb; 14(2):217-24. PubMed ID: 24269858
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nerve injury after lateral lumbar interbody fusion: a review of 919 treated levels with identification of risk factors.
    Lykissas MG; Aichmair A; Hughes AP; Sama AA; Lebl DR; Taher F; Du JY; Cammisa FP; Girardi FP
    Spine J; 2014 May; 14(5):749-58. PubMed ID: 24012428
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effectiveness and safety of recombinant human bone morphogenetic protein-2 versus local bone graft in primary lumbar interbody fusions.
    Adams CL; Ogden K; Robertson IK; Broadhurst S; Edis D
    Spine (Phila Pa 1976); 2014 Jan; 39(2):164-71. PubMed ID: 24153173
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of transforaminal lumbar interbody fusion outcomes in patients receiving rhBMP-2 versus autograft.
    Khan TR; Pearce KR; McAnany SJ; Peters CM; Gupta MC; Zebala LP
    Spine J; 2018 Mar; 18(3):439-446. PubMed ID: 28822825
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Retrograde ejaculation after anterior lumbar interbody fusion with and without bone morphogenetic protein-2 augmentation: a 10-year cohort controlled study.
    Comer GC; Smith MW; Hurwitz EL; Mitsunaga KA; Kessler R; Carragee EJ
    Spine J; 2012 Oct; 12(10):881-90. PubMed ID: 23098617
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparison of radiographic and clinical outcomes of anterior lumbar interbody fusion performed with either a cellular bone allograft containing multipotent adult progenitor cells or recombinant human bone morphogenetic protein-2.
    Lee DD; Kim JY
    J Orthop Surg Res; 2017 Aug; 12(1):126. PubMed ID: 28841904
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Complications with recombinant human bone morphogenetic protein-2 in posterolateral spine fusion associated with a dural tear.
    Glassman SD; Gum JL; Crawford CH; Shields CB; Carreon LY
    Spine J; 2011 Jun; 11(6):522-6. PubMed ID: 20598649
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of motor evoked potentials during lateral lumbar interbody fusion reduces postoperative deficits.
    Riley MR; Doan AT; Vogel RW; Aguirre AO; Pieri KS; Scheid EH
    Spine J; 2018 Oct; 18(10):1763-1778. PubMed ID: 29505853
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Perioperative complications of recombinant human bone morphogenetic protein-2 on an absorbable collagen sponge versus iliac crest bone graft for posterior cervical arthrodesis.
    Crawford CH; Carreon LY; McGinnis MD; Campbell MJ; Glassman SD
    Spine (Phila Pa 1976); 2009 Jun; 34(13):1390-4. PubMed ID: 19440166
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Does recombinant human bone morphogenetic protein-2 use in adult spinal deformity increase complications and are complications associated with location of rhBMP-2 use? A prospective, multicenter study of 279 consecutive patients.
    Bess S; Line BG; Lafage V; Schwab F; Shaffrey CI; Hart RA; Boachie-Adjei O; Akbarnia BA; Ames CP; Burton DC; Deverin V; Fu KM; Gupta M; Hostin R; Kebaish K; Klineberg E; Mundis G; O'Brien M; Shelokov A; Smith JS;
    Spine (Phila Pa 1976); 2014 Feb; 39(3):233-42. PubMed ID: 24477081
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical sequelae after rhBMP-2 use in a minimally invasive transforaminal lumbar interbody fusion.
    Singh K; Nandyala SV; Marquez-Lara A; Cha TD; Khan SN; Fineberg SJ; Pelton MA
    Spine J; 2013 Sep; 13(9):1118-25. PubMed ID: 24029138
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transforaminal lumbar interbody fusion with rhBMP-2 in spinal deformity, spondylolisthesis, and degenerative disease--part 1: Large series diagnosis related outcomes and complications with 2- to 9-year follow-up.
    Crandall DG; Revella J; Patterson J; Huish E; Chang M; McLemore R
    Spine (Phila Pa 1976); 2013 Jun; 38(13):1128-36. PubMed ID: 23370679
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Retrograde ejaculation after anterior lumbar interbody fusion using rhBMP-2: a cohort controlled study.
    Carragee EJ; Mitsunaga KA; Hurwitz EL; Scuderi GJ
    Spine J; 2011 Jun; 11(6):511-6. PubMed ID: 21612985
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Posterior lumbar interbody fusion using recombinant human bone morphogenetic protein type 2 with cylindrical interbody cages.
    Haid RW; Branch CL; Alexander JT; Burkus JK
    Spine J; 2004; 4(5):527-38; discussion 538-9. PubMed ID: 15363423
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Complications of rhBMP-2 utilization for posterolateral lumbar fusions requiring reoperation: a single practice, retrospective case series report.
    Hoffmann MF; Jones CB; Sietsema DL
    Spine J; 2013 Oct; 13(10):1244-52. PubMed ID: 23973099
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Retrograde ejaculation following single-level anterior lumbar surgery with or without recombinant human bone morphogenetic protein-2 in 5 randomized controlled trials: clinical article.
    Burkus JK; Dryer RF; Peloza JH
    J Neurosurg Spine; 2013 Feb; 18(2):112-21. PubMed ID: 23199378
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bone Morphogenetic Proteins in Spinal Surgery: What Is the Fusion Rate and Do They Cause Cancer?
    Malham GM; Giles GG; Milne RL; Blecher CM; Brazenor GA
    Spine (Phila Pa 1976); 2015 Nov; 40(22):1737-42. PubMed ID: 26730525
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Complications associated with single-level transforaminal lumbar interbody fusion.
    Rihn JA; Patel R; Makda J; Hong J; Anderson DG; Vaccaro AR; Hilibrand AS; Albert TJ
    Spine J; 2009 Aug; 9(8):623-9. PubMed ID: 19482519
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Accelerating lumbar fusions by combining rhBMP-2 with allograft bone: a prospective analysis of interbody fusion rates and clinical outcomes.
    Slosar PJ; Josey R; Reynolds J
    Spine J; 2007; 7(3):301-7. PubMed ID: 17482113
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An institutional six-year trend analysis of the neurological outcome after lateral lumbar interbody fusion: a 6-year trend analysis of a single institution.
    Aichmair A; Lykissas MG; Girardi FP; Sama AA; Lebl DR; Taher F; Cammisa FP; Hughes AP
    Spine (Phila Pa 1976); 2013 Nov; 38(23):E1483-90. PubMed ID: 23873231
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 40.